Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma.

Journal of Materials Science. Materials in Medicine
Peifeng LiuYourong Duan

Abstract

This study aims to determine the sensitivity, specificity and accuracy of epidermal growth factor receptor monoclonal antibody (EGFRmAb) modified poly(lactic acid-co-l-lysine) nanoparticles (PLA-PLL-EGFRmAb) NPs delivery system to EGFR positive cancer cells. In the study, a new PLA-PLL-EGFRmAb NPs was prepared. The cellular cytotoxicity, cellular uptake, and the targeted effect for hepatocellular carcinoma of PLA-PLL-EGFRmAb NPs were investigated. In vitro, the findings of Flow cytometry and Confocal Laser scanning Biological Microscopy showed that PLA-PLL-EGFRmAb NPs can bind to hepatocellular carcinoma cells and were uptaken effectively. In vivo in the SMMC-7721 xenograft mouse model, PLA-PLL-EGFRmAb NPs could target to the tumor effectively, which demonstrated a better targeting. These results showed that the PLA-PLL-EGFRmAb NPs have the potential to be used as a target delivery carrier for tumor therapies.

References

Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·P S StaytonO W Press
Aug 11, 2001·Biochemical Society Transactions·A Sorkin
May 24, 2003·The European Respiratory Journal·A P MeertJ P Sculier
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fred R HirschWilbur A Franklin
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G SelvaggiG V Scagliotti
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Dec 29, 2004·Journal of Drug Targeting·Heidrun WartlickKlaus Langer
Aug 30, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiao-Bing XiongQiang Zhang
May 13, 2006·Journal of Materials Science. Materials in Medicine·Yourong DuanZhirong Zhang
Aug 8, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amitava MitraBruce R Line
Aug 9, 2007·Advanced Drug Delivery Reviews·Jaspreet K Vasir, Vinod Labhasetwar
Aug 21, 2007·Journal of Materials Science. Materials in Medicine·Hui YuYourong Duan
Nov 17, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·H EliyahuA J Domb
Jan 15, 2008·Urologic Oncology·Barbara Haley, Eugene Frenkel
May 2, 2008·Advanced Drug Delivery Reviews·Jesse B Wolinsky, Mark W Grinstaff
Jul 24, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Takashi YoshizawaYoshie Maitani
Oct 22, 2008·Advanced Drug Delivery Reviews·Dev Kumar ChatterjeeYong Zhang
Feb 3, 2009·Experimental and Molecular Pathology·Rajesh Singh, James W Lillard

❮ Previous
Next ❯

Citations

Dec 20, 2012·Nanomedicine·Alyssa M Master, Anirban Sen Gupta
Jan 29, 2014·Toxicology and Applied Pharmacology·Shenbagamoorthy SundarrajSoundarapandian Kannan
Sep 19, 2014·Journal of Drug Targeting·Priyanka TharkarRaida Al-Kassas
Aug 10, 2012·Journal of Drug Targeting·Shaheen SultanaMohammed Ali
Nov 23, 2011·Cancer Letters·Sukhwinder KaurSurinder K Batra
Sep 19, 2015·Journal of Biomolecular Structure & Dynamics·Chompoonut RungnimSupot Hannongbua
Nov 27, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jing-Jun YanXing-Xing He
Jul 7, 2016·Immunotherapy·Thomas CarterKerry Chester
Jan 1, 2020·Scientific Reports·Anshu KumariSharad Gupta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.